This excerpt taken from the HAE 8-K filed Oct 27, 2008.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 23, 2008 the Companys Board of Directors decided that Brian Concannon will be promoted to the position of President and CEO effective in April, 2009, succeeding Brad Nutter in this role. Mr. Concannon will also join the Companys Board of Directors at that time. Mr. Nutter will relinquish his role as President and CEO of the Company concurrently with Mr. Concannons assumption of those offices, and Mr. Nutter will remain an employee of the Company as Executive Chairman of the Companys Board of Directors.
Mr. Concannon (age 51) joined Haemonetics in September, 2003 as President of the Patient Division, following an eighteen year career with progressively responsible leadership roles with American Hospital Supply Corporation, Baxter Healthcare Corporation, Allegiance Healthcare and Cardinal Health Products and Services. In 2006, Mr. Concannon was promoted to President of Global Markets at Haemonetics, and in 2007 he was promoted to Chief Operating Officer of the Company.